Search - tctmd.com

Displaying 141 - 160 of 1541

Sort: Relevancy | Date

FDA Grants MACE Reduction Indication for Semaglutide

News Daily News

FDA Grants MACE Reduction Indication for Semaglutide

March 08, 2024

DISCHARGE Data Reassure on Use of CCTA in Older Chest-Pain Patients

News Daily News

DISCHARGE Data Reassure on Use of CCTA in Older Chest-Pain Patients

Michael O'Riordan

March 04, 2024

Real-life Patients Do Well With Intravascular Lithotripsy: Spanish Registry

News Daily News

Real-life Patients Do Well With Intravascular Lithotripsy: Spanish Registry

March 01, 2024

March 2024 Dispatch for the CV Team

News Opinion CV Team Dispatch

March 2024 Dispatch for the CV Team

March 01, 2024

High Lp(a) Levels Harmful in Patients With and Without ASCVD

News Daily News

High Lp(a) Levels Harmful in Patients With and Without ASCVD

Michael O'Riordan

February 27, 2024

One in Three Overweight MI Patients May Benefit From Semaglutide

News Daily News

One in Three Overweight MI Patients May Benefit From Semaglutide

February 26, 2024

Niacin, When Broken Down by the Body, Can Spur Inflammation

News Daily News

Niacin, When Broken Down by the Body, Can Spur Inflammation

February 22, 2024

Increased Lp(a) Ups CV Risk Regardless of hs-CRP Level

News Daily News

Increased Lp(a) Ups CV Risk Regardless of hs-CRP Level

Yael L. Maxwell

February 15, 2024

Salt Substitute Slashes New Hypertension Diagnoses: DECIDE-Salt

News Daily News

Salt Substitute Slashes New Hypertension Diagnoses: DECIDE-Salt

February 14, 2024

AEGIS-II Misses Primary Endpoint, Dealing New Blow to HDL Hypothesis

News Daily News

AEGIS-II Misses Primary Endpoint, Dealing New Blow to HDL Hypothesis

February 14, 2024

CTO Diagnosed, Now What? European Experts Offer Advice on Revascularization

News Daily News

CTO Diagnosed, Now What? European Experts Offer Advice on Revascularization

February 09, 2024

Evolocumab Reduces MACE in Patients With and Without Multivessel CAD: FOURIER

News Daily News

Evolocumab Reduces MACE in Patients With and Without Multivessel CAD: FOURIER

Michael O'Riordan

February 08, 2024

Universal Risk Tool Works Well in Both Primary and Secondary Prevention

News Daily News

Universal Risk Tool Works Well in Both Primary and Secondary Prevention

Michael O'Riordan

February 01, 2024

Obstructive CAD Can Be Left Alone Before TAVI, Observational Data Suggest

News Daily News

Obstructive CAD Can Be Left Alone Before TAVI, Observational Data Suggest

Michael O'Riordan

January 30, 2024

Even Low Levels of ApoB and LDL Linked With CAD, Mortality: UK Biobank

News Daily News

Even Low Levels of ApoB and LDL Linked With CAD, Mortality: UK Biobank

Michael O'Riordan

January 23, 2024

Erectile Dysfunction Drugs Don’t Mix Well With Nitrates After MI, PCI

News Daily News

Erectile Dysfunction Drugs Don’t Mix Well With Nitrates After MI, PCI

January 16, 2024

No Signs of Hypoglycemia Causing CVD in CAROLINA and CARMELINA

News Daily News

No Signs of Hypoglycemia Causing CVD in CAROLINA and CARMELINA

Michael O'Riordan

January 05, 2024

Top General Cardiology and CVD Prevention News of 2023

News Daily News

Top General Cardiology and CVD Prevention News of 2023

Yael L. Maxwell

January 03, 2024

TCTMD’s Top 10 Most Popular Stories for December 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for December 2023

December 28, 2023

Who Benefits Most From Semaglutide and How Long Will That Take?

News Daily News

Who Benefits Most From Semaglutide and How Long Will That Take?

December 19, 2023

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.